Metabolism and excretion of asoprisnil, a novel selective progesterone receptor modulator, in healthy female subjects

被引：0
|
作者：
Lee, Ronald
Grabowski, Brian
Mulford, Darcy
Castagnoli, Neal
Rottmann, Antje
Chwalisz, Kristof
机构：
[1] TAP Pharmaceut Prod Inc, DMPK, Lake Forest, IL USA
[2] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA
[3] Schering AG, Pharmacokinet Metab & Bioanalysis, D-1000 Berlin, Germany
[4] TAP Pharmaceut Prod Inc, Womens Hlth, Lake Forest, IL USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
268
引用
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [31] Metabolism and Excretion of [14C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male Subjects
    Grabowski, Brian A.
    Khosravan, Reza
    Vernillet, Laurent
    Mulford, Darcy J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (02): : 189 - 201
  • [32] Effects of the Selective Progesterone Receptor Modulator Asoprisnil on Uterine Artery Blood Flow, Ovarian Activity, and Clinical Symptoms in Patients with Uterine Leiomyomata Scheduled for Hysterectomy
    Wilkens, Julia
    Chwalisz, Kristof
    Han, Cong
    Walker, Jane
    Cameron, Iain T.
    Ingamells, Susan
    Lawrence, Alexandra C.
    Lumsden, Mary Ann
    Hapangama, Dharani
    Williams, Alistair R. W.
    Critchley, Hilary O. D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (12): : 4664 - 4671
  • [33] Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment
    Schultze-Mosgau, Marcus-Hillert
    Lasseter, Kenneth C.
    Marbury, Thomas
    Loewen, Stephanie
    Riecke, Kai
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (08): : 1030 - 1038
  • [34] BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies
    Wagenfeld, Andrea
    Bone, Wilhelm
    Schwede, Wolfgang
    Fritsch, Martin
    Fischer, Oliver M.
    Moeller, Carsten
    HUMAN REPRODUCTION, 2013, 28 (08) : 2253 - 2264
  • [35] Asoprisnil, a Selective Progesterone Receptor Modulator (SPRM), Inhibits Melanosome Export in B16F10 Cells and HEMn-DP Melanocytes
    Goenka, Shilpi
    R. Simon, Sanford
    MOLECULES, 2020, 25 (16):
  • [36] Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys
    Prakash, Chandra
    Johnson, Kim A.
    Schroeder, Clinton M.
    Potchoiba, Michael J.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (09) : 1753 - 1769
  • [37] A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells
    Chen, W
    Ohara, N
    Wang, JY
    Xu, Q
    Liu, J
    Morikawa, A
    Sasaki, H
    Yoshida, S
    Demanno, DA
    Chwalisz, K
    Maruo, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04): : 1296 - 1304
  • [38] Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects
    Lantz, RJ
    Gillespie, TA
    Rash, TJ
    Kuo, F
    Skinner, M
    Kuan, HY
    Knadler, MP
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) : 1142 - 1150
  • [39] Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
    Teng, Renli
    Oliver, Stuart
    Hayes, Martin A.
    Butler, Kathleen
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1514 - 1521
  • [40] Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects
    Bhattacharya, Indranil
    Tarabar, Sanela
    Liang, Yali
    Pradhan, Vivek
    Owens, Jane
    Oemar, Barry
    CLINICAL THERAPEUTICS, 2016, 38 (06) : 1401 - 1416
12345